Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...

If you're a parent or guardian looking to keep your kids entertained during Spring Break 2025, the Louisville Free Public ...

A São Paul community theater shows how citizens are left to pick up the slack when cities fail to meet their residents’ needs ...

The use of ‘social prescriptions’ to improve children and young people’s wellbeing without medication can strengthen government policy on mental health support, University of Manchester researchers ...